First Human Trials for Recombinant Dengue Fever Vaccine

Phase one clinical trials to start for Dengue Fever Vaccine program

26-Aug-2009 - Acuvax Limited announces that the dengue fever vaccine is set to begin Phase 1 safety trials in the USA through its affiliate company Hawaii Biotech Inc. Hawaii Biotech Inc, has initiated this phase one clinical study with their monovalent dengue vaccine candidate. The double-blind, placebo ...

Hawaii Biotech Inc reports favourable phase 1 interim results to treat West Nile Virus

27-Feb-2009 - Hawaii Biotech, Inc., announced successful Phase 1 clinical trial results of its West Nile Virus vaccine in healthy volunteers. Hawaii Biotech is developing a West Nile recombinant sub-unit vaccine to induce protective immunity in recipients of the vaccine. The results demonstrated a ...

Avantogen’s CEO joins Hawaii Biotech Board of Directors

23-Oct-2008 - Avantogen Ltd announced the appointment of Dr William Ardrey, CEO of Avantogen, to the Board of Directors of Hawaii Biotech Inc effective 21 October 2008. Avantogen is focused on commercial licensing and revenue outcomes throughout the group. Avantogen believes that Dr. Ardrey’s appointment to ...

Avantogen’s Hawaii Biotech Inc. receives clinical trial support from Walter Reed Army Institute of Research

03-Sep-2008 - Avantogen Ltd announced additional support for the Dengue vaccine program developed by Hawaii Biotech Inc, in which Avantogen holds a significant investment stake. The Dengue clinical trial will be conducted as part of a broader trial at the clinical trials centre of the US Walter Reed Army ...

Avantogen's Hawaii Biotechnology Enters Clinic with West Nile Virus Vaccine

25-Jun-2008 - The Directors of Avantogen Ltd announced the clinical trials progress at Hawaii Biotech Inc, where Avantogen has a major shareholding. Dr William Ardrey, CEO of Avantogen, commented "We are pleased to see Hawaii Biotech advance to becoming a clinical stage company, and this also goes a long way ...

Prof Ian Frazer Appointed to Scientific Advisory Board of Avantogen's Hawaii Biotech, Inc.

04-Jun-2008 - Avantogen Ltd welcomes Professor Ian Frazer to the Scientific Advisory Board of Hawaii Biotech Inc. (HBI), where Avantogen owns a significant portion of the total equity. Prof Frazer is an immunologist and the 2006 Australian of the Year. HBI is a privately held vaccine development company ...